English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date：2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib  
A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension Journal article
Wang, Tao, Zhang, Yunran, Chi, Meiling, Zhao, Chen, Cao, Linlin, Tian, Chutong, Kamei, K., Zheng, Ying, Jiang, Qikun. A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension[J]. Asian Journal of Pharmaceutical Sciences, 2022, 17(6), 938-948.
Authors:  Wang, Tao;  Zhang, Yunran;  Chi, Meiling;  Zhao, Chen;  Cao, Linlin; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:10.7/9.0 | Submit date：2023/01/31
Glaucoma  Intraocular Pressure  Homologous Salt Engineering Strategy  Timolol Mesylate  Fixed-combination Timolol-netarsudil-latanoprost Ophthalmic Solution